Kainomet 500 Tablet contains Metformin 500 mg, an oral antihyperglycemic agent primarily used in the management of type 2 diabetes mellitus. Metformin belongs to the biguanide class and functions by decreasing hepatic glucose production, reducing intestinal glucose absorption, and enhancing insulin sensitivity in peripheral tissues, thereby improving glycemic control. It is indicated as monotherapy or in combination with other antidiabetic agents or insulin when diet and exercise alone do not achieve adequate glycemic regulation. Kainomet 500 is typically administered orally, with dosage individualized based on patient response and tolerability. Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort, which often subside with continued use. Metformin is contraindicated in patients with renal impairment, metabolic acidosis, or hypersensitivity to the drug. Regular monitoring of renal function and blood glucose levels is essential during therapy to minimize the risk of lactic acidosis, a rare but serious adverse effect. Kainomet 500 should be used cautiously in patients with hepatic dysfunction, congestive heart failure, or conditions predisposing to hypoxia. Proper adherence to prescribed dosage and lifestyle modifications is critical for optimal therapeutic outcomes in diabetes management.